Archive - Page 365 of 395 - Express Pharma

Drug pricing norms: Cost or MRP based?

Venus Remedies: Reinventing R&D

Regulatory woes of pharma SMEs (Part I)

Back to the roots —Landscaping OTC opportunities in the Indian ayurveda market

A holistic view of the HPAPI opportunity

Beyond the Ban

Sanofi ties up with Joslin Diabetes Center

Boehringer—Lilly alliance to launch first diabetes drug in India

CHMP recommends Novartis drug Afinitor for EU approval

Daiichi Sankyo and Ranbaxy launch hybrid business in Venezuela